McDaniel Terry & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$689K Sell
749
-6
-0.8% -$6.08K 0.06% 56
2025
Q4
$811K Buy
755
+10
+1% +$9.56K 0.07% 53
2025
Q3
$568K Buy
745
+2
+0.3% +$1.49K 0.05% 64
2025
Q2
$579K Sell
743
-34
-4% -$26.4K 0.05% 61
2025
Q1
$642K Sell
777
-1,018
-57% -$847K 0.06% 62
2024
Q4
$1.39M Buy
1,795
+1,000
+126% +$828K 0.11% 46
2024
Q3
$704K Buy
795
+327
+70% +$294K 0.06% 59
2024
Q2
$424K Sell
468
-168
-26% -$134K 0.04% 68
2024
Q1
$495K Buy
636
+200
+46% +$142K 0.04% 71
2023
Q4
$254K Hold
436
0.02% 79
2023
Q3
$234K Hold
436
0.02% 82
2023
Q2
$204K Buy
+436
New +$183K 0.02% 87

Other funds holding LLY

McDaniel Terry & Co's LLY Position: Q1 2026 in Review

McDaniel Terry & Co reduced its Eli Lilly (LLY) stake by 0.79% in Q1 2026, selling an estimated $6.08K and leaving 749 shares worth $689K. The position accounts for 0.06% of the portfolio, ranked #56.

McDaniel Terry & Co first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • McDaniel Terry & Co held 749 shares of Eli Lilly worth $689K as of Q1 2026.
  • McDaniel Terry & Co sold 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 0.06% of McDaniel Terry & Co's portfolio in Q1 2026, its #56 holding.
  • McDaniel Terry & Co first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • McDaniel Terry & Co's Eli Lilly position peaked at $1.39M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on McDaniel Terry & Co's 13F filing for Q1 2026, filed 5 May 2026.